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ABSTRACT 26 
Klebsiella spp. are frequently enriched in the gut microbiota of preterm neonates, and 27 
overgrowth is associated with necrotizing enterocolitis (NEC), nosocomial infections and late-onset 28 
sepsis. Little is known about the genomic and phenotypic characteristics of preterm-associated 29 
Klebsiella as previous studies have focussed on recovery of antimicrobial-resistant isolates or culture-30 
independent molecular analyses. The aim of this study was to better characterize preterm-associated 31 
Klebsiella populations using phenotypic and genotypic approaches. Faecal samples from a UK cohort 32 
of healthy and sick preterm neonates (n=109) were screened on MacConkey agar to isolate lactose-33 
positive Enterobacteriaceae. Whole-genome sequences were generated for Klebsiella spp., and 34 
virulence and antimicrobial resistance genes identified. Antibiotic susceptibility profiling, and in vitro 35 
macrophage and iron assays were undertaken for the Klebsiella strains. Metapangenome analyses with 36 
a manually curated genome dataset were undertaken to examine diversity of Klebsiella oxytoca and 37 
related bacteria in a publicly available shotgun metagenome dataset. Approximately one-tenth of 38 
faecal samples harboured Klebsiella spp. (Klebsiella pneumoniae, 7.3 %; Klebsiella 39 
quasipneumoniae, 0.9 %; Klebsiella grimontii, 2.8 %; Klebsiella michiganensis, 1.8 %). Isolates 40 
recovered from NEC- and sepsis-affected infants and those showing no signs of clinical infection (i.e. 41 
‘healthy’) encoded multiple -lactamases. No difference was observed between isolates recovered 42 
from ‘healthy’ and sick infants with respect to in vitro siderophore production (all encoded 43 
enterobactin in their genomes). All K. pneumoniae, K. quasipneumoniae, K. grimontii and K. 44 
michiganensis faecal isolates tested were able to reside and persist in macrophages, indicating their 45 
immune evasion abilities. Metapangenome analyses of published metagenomic data confirmed our 46 
findings regarding the presence of K. michiganensis in the preterm gut. There is little difference in the 47 
phenotypic and genomic characteristics of Klebsiella isolates recovered from ‘healthy’ and sick 48 
infants. Identification of -lactamases in all isolates may prove problematic when defining treatment 49 
regimens for NEC or sepsis, and suggests ‘healthy’ preterm infants contribute to the resistome. 50 
Refined analyses with curated sequence databases are required when studying closely related species 51 
present in metagenomic data.  52 
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Impact statement 65 
Polyphasic characterization of isolates recovered from the faeces of preterm infants has demonstrated 66 
that Klebsiella spp. recovered from these patients are genomically more diverse than previously 67 
recognized. All K. pneumoniae, K. quasipneumoniae, K. grimontii and K. michiganensis faecal 68 
isolates studied were able to reside and persist in macrophages, indicating their immune evasion 69 
abilities and potential for causing infections in at-risk infants. The identification of K. michiganensis 70 
in samples, and the abundance of K. michiganensis genomes in public repositories, adds to the 71 
growing body of evidence indicating that K. michiganensis is likely to be more clinically relevant than 72 
K. oxytoca in human-associated infections. Metapangenome analyses of publicly available shotgun 73 
metagenomic data confirmed the prevalence of K. michiganensis in the faeces of preterm infants, and 74 
highlighted the need for refined taxonomic analyses when splitting closely related species from one 75 
another in metagenomic studies. 76 
 77 
Data summary 78 
16S rRNA gene sequence data associated with this article have been deposited at 79 
DDBJ/ENA/GenBank under BioProject accession PRJEB34372. The Whole Genome Shotgun project 80 
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has been deposited at DDBJ/ENA/GenBank under BioProject accession PRJNA471164. The 81 
metagenome-assembled genomes are available from figshare. Published sequence data of Ward et al. 82 
(1), used to generate the metagenome-assembled genomes, are available under BioProject accession 83 
number 63661. 84 
 85 
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INTRODUCTION 87 
The gut microbiota encompasses bacteria, archaea, lower eukaryotes and viruses, with these 88 
microbes contributing to host gastrointestinal (GI) and systemic health. Host–microbiome interactions 89 
within the intestine are particularly important in neonates, contributing to development of the immune 90 
response, establishment of the gut microbiome and protection from infections (2,3). Term infants (i.e. 91 
gestation 37 weeks) are rapidly colonised after exposure to the mother’s microbiota and the 92 
environment, with streptococci and Enterobacteriaceae dominating in the initial phases (2), and 93 
Bifidobacterium spp. becoming prominent as the infant grows (2). 94 
In contrast, colonization of preterm infants (i.e. <37 weeks’ gestation) occurs in neonatal 95 
intensive care units (NICUs) and is shaped by the significant number of antibiotics (‘covering’ (i.e. to 96 
cover possible early onset infection from birth) and treatment) these infants receive in the first days 97 
and weeks post birth. The microbiota in preterm infants is enriched for bacteria such as 98 
Enterobacteriaceae, Enterococcus and Staphylococcus (4,5). 99 
Critically, colonization of these at-risk infants with potentially pathogenic taxa, in concert with 100 
an unstable microbiome, and immaturity of their GI tract and immune system, is thought to contribute 101 
to nosocomial infections such as late-onset sepsis (LOS) or necrotizing enterocolitis (NEC) (6–12). 102 
The family Enterobacteriaceae comprises more than 25 genera of catalase-positive, oxidase-103 
negative Gram-negative bacteria and encompasses many pathogens [e.g. Escherichia (Esc.) coli, 104 
Klebsiella pneumoniae, Shigella (Shi.) dysenteriae, Enterobacter (Ent.) cloacae, Serratia (Ser.) 105 
marcescens and Citrobacter spp.] (13). While coagulase-negative staphylococci are the most common 106 
cause of LOS in preterm infants, Enterobacteriaceae that translocate from the preterm gut to the 107 
bloodstream also cause this condition (8,9). In addition, Enterobacteriaceae are associated with 108 
higher morbidity than the staphylococci, and blooms in Proteobacteria – thought to be linked to 109 
impaired mucosal barrier integrity – have been reported immediately prior to the diagnosis of LOS 110 
(8,9,14). Predictions made from shotgun metagenomic data show replication rates of all bacteria – and 111 
especially the Enterobacteriaceae and Klebsiella – are significantly increased immediately prior to 112 
NEC diagnosis (15). This altered gut microbiome influences intestinal homeostasis and contributes to 113 
NEC (16), in tandem with the immature preterm immune system contributing to intestinal pathology 114 
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in response to blooms of Proteobacteria. 115 
Associations between Klebsiella-related operational taxonomic units (OTUs) and the 116 
development of NEC have been noted, suggesting members of this genus contribute to the aetiology 117 
of NEC in a subset of patients (17,18). Although Sim et al. (17) found one of their two distinct groups 118 
of NEC infants had an overabundance of a Klebsiella OTU, these researchers failed to identify a 119 
single predominant species of Klebsiella, recovering representatives of several genera (K. 120 
pneumoniae, Klebsiella oxytoca, Klebsiella aerogenes, Ent. cloacae, Esc. coli and Ser. marcescens) 121 
from samples. Klebsiella spp. and their fimbriae-encoding genes were significantly enriched in faeces 122 
collected immediately prior to the onset of NEC in a US infant cohort. These fimbriae may contribute 123 
to the overexpression of TLR4 receptors observed in preterm infants (15). Confirming the role of 124 
these bacteria in NEC will require reproducing certain aspects of the disease in model systems, using 125 
well-characterized bacteria recovered from preterm infants (14,17). 126 
To date, there is limited information on the genomic and phenotypic features of preterm-127 
associated Klebsiella spp. Thus, to characterise these important opportunistic pathogens, and to build 128 
a collection of preterm-associated Klebsiella strains for use in future mechanistic studies relevant to 129 
preterm-infant health, we isolated and characterized (phenotypically and genomically) bacteria from a 130 
cohort of preterm neonates enrolled in a study at the Norfolk and Norwich University Hospital 131 
(NNUH), Norwich, United Kingdom. Recovered Klebsiella isolates were subject to additional 132 
phenotypic tests that complemented genomic data. In addition, for the increasingly important species 133 
K. oxytoca, in which our laboratories have a specific interest, metapangenome analyses were 134 
undertaken to better understand the prevalence and potential virulence of this organism and related 135 
species in the context of the preterm neonate gut microbiota. 136 
 137 
METHODS 138 
Collection of faecal samples. Faeces were collected from premature neonates (<37 weeks’ gestation) 139 
(Supplementary Table 1). The Ethics Committee of the Faculty of Medical and Health Sciences of 140 
the University of East Anglia (Norwich, UK) approved this study. The protocol for faeces collection 141 
was laid out by the Norwich Research Park (NRP) Biorepository (Norwich, UK) and was in 142 
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accordance with the terms of the Human Tissue Act 2004 (HTA), and approved with licence number 143 
11208 by the Human Tissue Authority. Infants admitted to the NICU of the NNUH were recruited by 144 
doctors or nurses with informed and written consent obtained from parents. Collection of faecal 145 
samples was carried out by clinical researchers and/or research nurses, with samples stored at -80 °C 146 
prior to DNA extraction. 147 
 148 
16S rRNA gene sequencing and analyses. DNA was extracted from samples using the FastDNA 149 
SPIN Kit for Soil (MP Biomedicals) and processed for sequencing and analyses as described 150 
previously (19). This 16S rRNA gene sequence data associated with this project have been deposited 151 
at DDBJ/ENA/GenBank under BioProject accession PRJEB34372. 152 
 153 
Isolation of bacteria and biochemical characterization. For isolation work, a single faecal sample 154 
from each baby (n=109; Supplementary Table 1) was thawed and 0.1 g homogenised in 1 mL TBT 155 
buffer (100 mM Tris/HCl, pH 8.0; 100 mM NaCl; 10 mM MgCl2•6H2O). Homogenates were serially 156 
diluted 10-1 to 10-4 in TBT buffer. Aliquots (50 µL) of homogenate were spread on MacConkey agar 157 
no. 3 (Oxoid Ltd) plates in triplicate and incubated aerobically at 37 °C overnight. 158 
Differential counts (based on colony morphology) of all lactose-positive (i.e. pink) colonies 159 
were made in triplicate to calculate colony-forming units (CFUs) per gramme wet-weight faeces. One 160 
of each colony type per plate was selected and re-streaked on MacConkey agar three times to purify, 161 
incubating aerobically at 37 °C overnight each time. A single colony from each pure culture was re-162 
suspended in 5 mL of sterile distilled water; the API 20E kit (bioMérieux) was used according to the 163 
manufacturer’s instructions to give preliminary identities for each of the isolates recovered. 164 
 165 
DNA extraction, whole-genome sequencing and assembly. DNA was extracted using a phenol–166 
chloroform method fully described previously (20) from overnight cultures of strains, and sequenced 167 
using the 96-plex Illumina HiSeq 2500 platform to generate 125 bp paired-end reads (21). Raw data 168 
provided by the sequencing centre were checked using fastqc v0.11.4 169 
(https://www.bioinformatics.babraham.ac.uk/projects/fastqc/); no adapter trimming was required, and 170 
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reads had an average Phred score >25. MetaPhlAn2.6 (22) was used to identify which species genome 171 
sequences represented. According to the results given by MetaPhlAn2.6, appropriate reference 172 
genomes were retrieved from Ensembl Genome (http://bacteria.ensembl.org/index.html) to guide 173 
reference-based assembly using BugBuilder v1.0.3b1 (default settings for Illumina data) (23). 174 
Summary statistics for the Klebsiella genome sequences generated in this study, including accession 175 
numbers, can be found in Supplementary Table 2. This Whole Genome Shotgun project has been 176 
deposited at DDBJ/ENA/GenBank under BioProject accession PRJNA471164. 177 
 178 
Genome analyses. Average nucleotide identity (ANI) between genome sequences of isolates and 179 
reference strains (Klebsiella grimontii 06D021T, GCA_900200035; K. oxytoca 2880STDY5682490, 180 
GCA_900083895.1; Klebsiella michiganensis DSM 25444T, GCA_002925905) was determined using 181 
FastANI (default settings) (24). 182 
K. oxytoca, K. michiganensis and K. grimontii genomes were uploaded to the Klebsiella 183 
oxytoca/michiganensis MLST website (https://pubmlst.org/koxytoca/) sited at the University of 184 
Oxford (25) on 28 July 2019 to determine allele number against previously defined house-keeping 185 
genes (rpoB, gapA, mdh, pgi, phoE, infB and tonB). K. pneumoniae genomes were analysed using the 186 
Institut Pasteur MLST database (https://bigsdb.pasteur.fr/klebsiella/klebsiella.html). Kleborate (26,27) 187 
and Kaptive (28) were used to identify capsular type and O antigen type.  188 
Virulence genes were identified by BLASTP of genome amino acid sequences against the 189 
Virulence Factors of Pathogenic Bacteria Database (VFDB; ‘core dataset’ downloaded 27 July 2019) 190 
(29); results are reported for >70 % identity and 90 % query coverage. Antimicrobial resistance 191 
(AMR) genes were identified by BLASTP against the Comprehensive Antibiotic Resistance Database 192 
(CARD) download (27 July 2019; protein homolog dataset) (30); only strict and perfect matches with 193 
respect to CARD database coverage and bit-score cut-off recommendations are reported. 194 
Genomic traits were visualized using anvi’o-5.5 (31) according to the pangenomic workflow. 195 
Briefly, for each figure presented herein, genomes were used to create an anvi’o contigs database, 196 
which contained ORFs predicted using Prodigal v2.6.3 (32). A multiple-sequence alignment was 197 
created using BLASTP. Markov CL algorithm (33) was used to identify gene clusters (--mcl-inflation 198 
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10; high sensitivity for identifying gene clusters of closely related species or strain level). Gene 199 
clusters and genomes were organized using Euclidean distance and Ward linkage, with results 200 
visualized using GoogleChrome.  201 
 202 
Phenotypic characterization of Klebsiella isolates 203 
Iron assays. Pre-cultures of Klebsiella isolates (5 mL) were grown overnight in LB broth (37 °C, 160 204 
rpm). Aliquots (500 µL) were harvested (4000 rpm, 20 min) and the cell pellets washed twice with 205 
PBS. The cell suspensions (50 µL) were used to inoculate 5 mL cultures containing M9 minimal 206 
medium (Na2HPO4, 6.9 g/L; KH2PO4, 3 g/L; NaCl, 0.5 g/L; NH4Cl, 1 g/L; CaCl2, 0.1 mM; MgSO4, 2 207 
mM; 0.2 % glucose) at 37 °C. At 20 h, bacterial growth and siderophore production were measured 208 
using the CAS assay (34). An aliquot (100 μL) of the cell culture supernatant was mixed with CAS 209 
dye (100 μL), followed by the shuttle solution (4 μL) and siderophore production monitored at 620 210 
nm at 4 h using a BioRad Benchmark Plus microplate spectrophotometer. A decrease in the blue 211 
colour of the CAS dye was measured using uninoculated medium as control. The estimated amount of 212 
total siderophore produced by Klebsiella isolates was calculated using the CAS standard curve based 213 
upon a desferrioxamine B standard (1:1). 214 
 215 
Macrophage assays. All strains were grown on LB broth + 1.5 % agar and incubated overnight at 37 216 
°C. THP-1 monocytes were obtained from ATCC (TIB-202) and were maintained in RPMI (Gibco: 217 
72400021) plus 10 % heat-inactivated foetal bovine serum (FBS; Gibco: 10500064) in a humidified 218 
incubator at 37 °C with 5 % CO2. THP-1 monocytes were differentiated into macrophages in RPMI + 219 
10 mM HEPES + 10 % FBS + 10 ng/mL phorbol 12-myristate 13-acetate (PMA; Sigma) and seeded 220 
at 1×105 cells per well of a 96-well tissue culture dish and incubated for 15 h. Overnight cultures of 221 
bacteria were diluted 1:100 into fresh LB broth and grown until mid-exponential phase. Bacteria were 222 
then washed twice with PBS and diluted to 1×107 cfu/mL in RPMI + 10 mM HEPES + 10 % FBS and 223 
100 μL of bacteria was added to each well. Plates were then centrifuged at 300 g for 5 min to 224 
synchronize infections. Bacteria–macrophage co-culture was incubated at 37 °C/5 % CO2 for 30 min 225 
to allow for phagocytosis. Cells were then washed three times in PBS and medium was replaced with 226 
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above culture medium supplemented with 300 μg/mL gentamicin and 100 units/mL polymyxin B to 227 
eliminate extracellular bacteria. Cell were again incubated at 37 °C/5 % CO2 for 1.5 h. Cells were then 228 
washed three times with PBS and medium for cells for later time points was replaced with culture 229 
medium supplemented with 300 μg/mL gentamicin and incubated for a further 4.5 h. Intracellular 230 
bacterial load was enumerated by lysing macrophages in PBS + 1% Triton X-100 for 10 min at room 231 
temperature, serially diluting cultures and plating on LB agar. Plates were incubated overnight at 37 232 
°C and colonies counted the following day. 233 
 234 
Calculation of antibiotic minimal inhibitory concentration (MIC) for the Klebsiella isolates. 235 
Broth microdilution method was used to calculate the MIC of the Klebsiella isolates. Serial two-fold 236 
dilutions of benzylpenicillin, gentamicin, and meropenem were added to sterile nutrient broth. The 237 
antibiotics used in this assay were supplied by the NICU of NNUH. Inoculum for each of the isolates 238 
was prepared using 10 mL from a fresh overnight culture. Microplates were incubated for 24 h at 37 239 
°C under aerobic conditions. Optical density was monitored using a plate reader (BMG Labtech, UK) 240 
at 595 nm. MICs were determined as the lowest concentration of antibiotic inhibiting any bacterial 241 
growth. All experiments were repeated in triplicate. For the aminoglycoside gentamicin and the 242 
carbapenem meropenem, Klebsiella (Enterobacteriaceae) breakpoints were determined according to 243 
European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines (version 8.1, 244 
published 16 May 2018, 245 
http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_8.1_Breakpoin246 
t_Tables.pdf). No EUCAST data were available for benzylpenicillin (EUCAST states this 247 
aminopenicillin has no clinically useful activity against Enterobacteriaceae). 248 
 249 
Estimation of abundance of K. oxytoca in shotgun metagenomic data. We chose to analyse a 250 
published preterm gut metagenome dataset (1) in this study, as it had been previously used to identify 251 
associations between uropathogenic Esc. coli and NEC. Trimmed, human-filtered, paired-end read 252 
data deposited in the Sequence Read Archive by Ward et al. (1) are available under BioProject 253 
accession number 63661. Information on Ward samples included in this study can be found in 254 
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Supplementary Table 3. Ward et al. (1) used MetaPhlAn to determine abundance of bacteria in 255 
samples. However, the marker genes used to enumerate K. oxytoca in the MetaPhlAn2.6 database are 256 
derived from 11 genomes, five of which are not K. oxytoca (Raoultella ornithinolytica 10-5246, 257 
GCF_000247895; K. michiganensis E718, GCF_000276705; K. michiganensis Kleb_oxyt_10-258 
5250_V1, GCF_000247915; K. michiganensis KCTC 1686, GCF_000240325; K. michiganensis 259 
Kleb_oxyt_10-5242_V1, GCF_000247835). Therefore, relative abundance of bacteria was instead 260 
determined using Centrifuge (35). While MetaPhlAn2.6 relies on a pre-compiled database of unique 261 
marker genes for determining taxonomic abundance, the Centrifuge database can be updated at will 262 
using genomes downloaded from NCBI. A bacteria- and archaea-specific complete genome database 263 
was generated for use with Centrifuge via NCBI on 1 July 2018. Species-level abundances, based on 264 
read-level data, for K. oxytoca and K. michiganensis in the study of Ward et al. (1) were determined. 265 
(NB: K. grimontii genomes were not included in the Centrifuge database, nor are they included in 266 
MetaPhlAn2.6 or the most-recent version of Kraken2.) 267 
 268 
Metapangenome analyses of K. oxytoca, K. michiganensis and K. grimontii. A total of 162 K. 269 
oxytoca-related whole-genome sequences were retrieved from GenBank on 31 May 2018 270 
(Supplementary Table 4). On the basis of blaOXY, phylogenetic and ANI analyses (36), these had 271 
been confirmed to belong to K. oxytoca (n=64), K. grimontii (n=24) and K. michiganensis (n=74) 272 
(Supplementary Table 5). Prokka v1.13.3 (37) was used to annotate the 162 downloaded and five 273 
infant genomes. The resulting .gff files were subject to pangenome analyses using Roary v3.12.0 274 
(default settings) (38). Genes present in 165–167 strains were defined as the core cluster, while those 275 
present in 25–164 strains were defined as the accessory cluster. Remaining genes that only existed in 276 
single strains were classified into strain-specific clusters. FastTree v2.1.10 (39) was used to generate a 277 
phylogenetic tree from the core gene alignment, with the tree visualized using FigTree v1.4.4 278 
(http://tree.bio.ed.ac.uk/software/figtree/). 279 
PanPhlAn (panphlan_pangenome_generation.py v1.2.3.6; panphlan_profile.py v1.2.2.3; 280 
panphlan_map.py v1.2.2.5; (40)) was used to profile strains within metagenomes using the Roary-281 
generated pangenome dataset. Gene-family clusters across all 167 available genomes and centroid 282 
 12 
sequence files outputted from Roary were uploaded to PanPhlAn to build a Bowtie2-indexed 283 
pangenome database, against which raw reads (concatenated read pair files) were mapped using 284 
Bowtie2 v2.3.0. The coverages of all gene positions were detected and extracted using samtools 285 
v1.4.1, and then integrated to a gene-family coverage profile for each sample. Pangenome-related 286 
strains were predicted to exist if a consistent and similar coverage depth across a set of 5774 gene 287 
families was detected under the non-default parameters of PanPhlAn (--min_coverage 1, --left_max 288 
1.70, --right_min 0.30; panphlan_profile.py). Principal component analysis (PCA) was performed on 289 
500 accessory genes randomly selected from the pangenome using the R package FactoMineR (41), 290 
allowing us to distinguish different species at the gene level. 291 
 292 
Recovery of metagenome-assembled genomes (MAGs) from metagenomes. For metagenome 293 
samples in which K. oxytoca-related strains were identified using PanPhlAn, attempts were made to 294 
recover them as MAGs. All reads in samples were mapped against the pangenome database using 295 
Bowtie2 and mapped paired-end reads were extracted by using FastQ Screen v0.11.3 as new fastq 296 
files (with parameter --tag, --filter 3). The extracted paired-end reads were assembled using SPAdes 297 
v3.12.0 (42). These assemblies were known as original MAGs. A genome size of 5.5 Mb was set as a 298 
strict threshold: any assembly whose genome size was lower than this threshold was not considered in 299 
downstream analyses. FastANI was applied to calculate the ANI (cut-off 95 %) between MAGs and 300 
the three species reference genomes to double-check the predominant species in corresponding 301 
samples. The quality of each MAG was assessed using CheckM v1.0.18 (43). 302 
A small number of the original MAGs were of high quality (44), but some contained a large 303 
number of contaminant contigs. All original MAGs were decontaminated as follows. Coding 304 
sequences of species-specific genomes in the pangenome were predicted using Prodigal v2.6.3 (Hyatt 305 
et al., 2010) with default settings and resulting multi-FASTA files containing protein sequences were 306 
concatenated to single files, which were used to build K. oxytoca-, K. michiganensis- and K. 307 
grimontii-specific databases in Diamond (45) format. Contigs of the original MAGs were aligned 308 
against the corresponding database under different minimum identity (%) cutoffs to report sequence 309 
alignments (with parameter --id 95, 96, 97, 98, 99 and 100). All unmapped contigs and contigs <500 310 
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nt in length were discarded from the original MAGs and the quality of new MAGs acquired was 311 
evaluated again using CheckM, to identify a Diamond BLAST identity threshold at which 312 
decontamination was effective while maintaining high genome completeness. 313 
 314 
RESULTS AND DISCUSSION 315 
Composition of the microbiota of preterm neonates 316 
First faecal samples available after birth were collected from 109 hospitalized preterm infants 317 
(n = 50 female; n = 59 male) in the NICU of the NNUH (Supplementary Table 1; Figure 1a). On 318 
the basis of 16S rRNA gene sequencing data, Enterobacteriaceae were detected in the faeces of 42 319 
(38.5 %) of the infants (Figure 1b). 320 
All faecal samples were screened for Enterobacteriaceae using MacConkey agar no. 3 321 
(Figure 1c). Forty-six (42.2 %) samples were positive for Enterobacteriaceae (n = 9 lactose-negative, 322 
carriage rate 8.3 %; n = 37 lactose-positive, carriage rate 33.9 %). Lactose-negative isolates were not 323 
characterized further. API 20E was used to provide tentative identification of LPE from 36 neonates 324 
(isolate could not be resuscitated for neonate P054) (Figure 1d). Of the 36 infants from whose faeces 325 
isolates were recovered, 23 were healthy, three had or were subsequently diagnosed with NEC, eight 326 
had suspected sepsis, one had an operation for gastroschisis and one was diagnosed with an eye 327 
infection after the faecal sample was taken (Supplementary Table 1). 328 
 329 
Whole-genome sequencing of neonatal faecal LPE 330 
Whole-genome sequences were obtained for 56 LPE. MetaPhlAn2.6 was used to assign 331 
identities to genomes (not shown). Among the 56 isolates sequenced, 20 were identified as K. 332 
pneumoniae (carriage rate 8.3 %; Supplementary Table 2), 14 were Ent. cloacae complex (carriage 333 
rate 11.9 %), 13 were Esc. coli (carriage rate 11.9 %), five were K. oxytoca (Supplementary Table 334 
2), two were Citrobacter freundii (carriage rate 1.8 %; (46)), one was Citrobacter murliniae (carriage 335 
rate 0.9 %; (46)) and one was R. ornithinolytica (carriage rate 0.9 %; (47)). Esc. coli and Ent. cloacae 336 
complex isolates will be discussed in detail elsewhere. MetaPhlAn2.6-generated identities matched 337 
those given by API 20E (Supplementary Table 2). 338 
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Reference-based assembly of genomes was performed using BugBuilder (23) 339 
(Supplementary Table 2). To determine whether preterm neonates may harbour more than one strain 340 
of a species in their faecal microbiota, nine isolates (#64–#73) were collected from neonate P008. 341 
These had all been identified as K. pneumoniae by API 20E and genome data. ANI across the nine 342 
isolates was >99.99 %. To determine whether the isolates were identical, gene content analysis was 343 
performed using Roary (38). The average number of CDSs among these isolates was 5,385 (6.25) 344 
(Supplementary Figure 1a–d). Anvi’o showed the isolates were highly similar (Supplementary 345 
Figure 1e). Isolates of the same species from other neonates were also found to be identical to one 346 
another (#102 and #103 from P080; #118 and #119 from P124). For sets of identical isolates, only one 347 
was taken forward for further analyses. This left 14 distinct Klebsiella strains (9 K. pneumoniae; 5 K. 348 
oxytoca) for further analyses. 349 
 350 
Genome analyses of K. pneumoniae strains 351 
K. pneumoniae is a commensal of the human gut microbiota and can cause nosocomial 352 
infections, NEC and LOS in premature neonates (9,17,48–50),(51). The genetic backgrounds of the 353 
neonate isolates were explored, to determine virulence and AMR genes encoded within the strains’ 354 
genomes. 355 
Each isolate was genetically different: i.e. no two infants harboured the same strain of K. 356 
pneumoniae (Supplementary Figure 2). ANI analyses with representative strains of the seven 357 
phylogenetic groups of K. pneumoniae (52) showed eight of the neonatal isolates were K. pneumoniae 358 
(98.83–98.98 % ANI with K. pneumoniae ATCC 13883T (GCA_000742135)) and one (#91) was K. 359 
quasipneumoniae (98.5 % ANI with Klebsiella quasipneumoniae subsp. quasipneumoniae 01A030T 360 
(GCA_000751755)). MLST identified six STs within the K. pneumoniae strains (Figure 2a). K. 361 
quasipneumoniae #91 had a novel mdh allele, so no ST could be specified for this strain. None of the 362 
STs belonged to clonal complex (CC) 258, responsible for hospital outbreaks due to its frequent 363 
carriage of KPC and other acquired AMR genes (53). The capsule of K. pneumoniae and related 364 
species is considered one of its major virulence factors. K1, K2 and K5 capsular types and 365 
hypervirulent types have strong associations with human infectious diseases (54,55). None of our 366 
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neonatal isolates had a capsular type commonly associated with infections or hypervirulent K. 367 
pneumoniae, though K7, K10, K11, K16 and K38 isolates have previously been recovered from 368 
clinical samples in Taiwan (56). Although the capsular type of strain #74 was identified as K62 with 369 
99.33 % confidence and 100 % coverage, there was one gene (KL62-12, according to Kaptive) 370 
missing from the locus, leaving it a non-perfect match. Further analyses showed the genes associated 371 
with K62 to be disrupted in strain #74 and not encoded on a contiguous stretch of DNA 372 
(Supplementary Figure 3). Of the nine K. pneumoniae strains analysed using Kleborate (26,27), 373 
O1v1 and O1v2 were represented equally among the O-antigen types (n =4 for both). These can be 374 
distinguished using genomic data but are serologically cross-reactive (27). K. quasipneumoniae #91 375 
was O3/O3a. 376 
The vast majority (e.g. ~90 % in the NNUH NICU) of preterm infants receive antibiotics during 377 
their NICU stay, often started routinely from admission (i.e. ‘covering’) if they are born very 378 
premature and/or very low birth weight. Administration of antibiotics can lead to disruption of early 379 
colonization by microbes, potentially encouraging growth of opportunistic pathogens such as LPE, 380 
creating a selection pressure that may promote development of AMR. All strains encoded homologues 381 
of acrB, acrD, marA, emrR, CRP, mdtB, mdtC, baeR, Escherichia mdfA, PmrF, msbA, OmpK37, 382 
KpnE, KpnF, KpnG, KpnH and Escherichia ampH -lactamase, associated with antibiotic efflux and 383 
its regulation (acrB, acrD, marA, emrR, CRP, mdtB, mdtC, baeR) (57–59) and resistance to: 384 
aminoglycosides; cationic antimicrobial peptides and antibiotics such as polymyxin (PmrF (60)); 385 
chloramphenicol (mdfA (61)), cefotaxime and cefoxitin (OmpK37); cefepime, ceftriaxone, colistin, 386 
erythromycin, rifampin, tetracycline, streptomycin as well as enhanced sensitivity toward sodium 387 
dodecyl sulfate, deoxycholate, dyes, benzalkonium chloride, chlorohexidine, and triclosan (KpnE, 388 
KpnF (62)); azithromycin, ceftazidime, ciprofloxacin, ertapenem, erythromycin, gentamicin, 389 
imipenem, ticarcillin, norfloxacin, polymyxin-B, piperacillin, spectinomycin, tobramycin, and 390 
streptomycin (KpnG, KpnH (63)); -lactams and penicillin (Escherichia ampH -lactamase (64)). As 391 
expected, core genes blaSHV and blaOKP, respectively, were found in K. pneumoniae and K. 392 
quasipneumoniae genomes (53). K. quasipneumoniae #91 also encoded homologues of the acquired 393 
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AMR gene emrB (a translocase that recognizes substrates including carbonyl cyanide m-394 
chlorophenylhydrazone, nalidixic acid and thioloactomycin) and bacA (confers resistance to 395 
bacitracin) (Figure 2a). Plasmid-encoded blaSHV enzymes represent an important subgroup of class A 396 
-lactamases, while chromosomally encoded -lactamase blaOKP cannot hydrolyse extended-spectrum 397 
cephalosporins (65). Homologues of the core AMR genes oqxA and oqxB (encoding OqxAB, a 398 
plasmid-encoded efflux pump that confers resistance to fluoroquinolones) were encoded by #64, #74, 399 
#91, #95, #115 and #118. Strains #64 and #95 encoded homologues of FosA6, while #74, #85, #92, 400 
#115 and #118 encoded homologues of FosA5 (both gene products confer resistance to fosfomycin, 401 
and are core AMR genes (53)). 402 
While the majority of the neonatal K. pneumoniae strains did not represent known pathogenic 403 
lineages, virulence factors were detected in their genomes using VFDB (Figure 2b). The host limits 404 
iron availability within the GI tract to prevent colonization by pathogens and bacterial overgrowth. 405 
However, Klebsiella spp. have evolved numerous mechanisms to circumvent these defences. Thus, 406 
we determined whether gene clusters associated with iron uptake and siderophore systems (i.e. 407 
enterobactin, yersiniabactin, aerobactin, colibactin, salmochelin) were present in the strains. All 408 
strains encoded enterobactin, while only #115 encoded an additional system (yersiniabactin) (Figure 409 
2b). All strains encoded Esc. coli common pilus, OmpA, Hsp60, type 3 fimbriae, ferric aerobactin 410 
receptor IutA and the AcrAB efflux pump. All strains except #102 encoded type 1 fimbriae; all strains 411 
except K. quasipneumoniae #91 encoded typical K. pneumoniae lipopolysaccharide (LPS) according 412 
to VFDB (>70 % amino acid identity and 90 % query coverage). K. quasipneumoniae #91 encoded 413 
thin aggregative fimbriae, associated with biofilm formation and adhering to human mucosal or 414 
epithelial surfaces. Incomplete coverage of Klebsiella capsule genes is likely due to the limited 415 
database of VFDB compared with those used to populate Kaptive and Kleborate. Kaptive had shown 416 
#91 to be K11 and O3/O3a. The core LPS region of #91 was identified using the waa gene cluster 417 
(66); WaaL clustering with an 80 % threshold showed the strain had LPS core type 1 (67) 418 
(Supplementary Figure 4). 419 
 420 
Whole-genome analyses of isolates tentatively identified as K. oxytoca 421 
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K. oxytoca is a minor member of the human gut microbiota, recovered at low levels from the 422 
faeces of 1.6–9 % of healthy adults (68). Toxigenic K. oxytoca is a causative agent of antibiotic-423 
associated haemorrhagic colitis, a condition affecting mainly young and otherwise healthy outpatients 424 
after brief treatment with penicillin derivatives (69). K. oxytoca has been detected in the faeces of a 425 
subset of preterm infants via cultivation or shotgun metagenomics, but its association with preterm-426 
associated infections is unknown (1,17,70). At the DNA level, bacteria characterized phenotypically 427 
as K. oxytoca actually represent six phylogroups/distinct species: Ko1, K. michiganensis; Ko2, K. 428 
oxytoca; Ko3, ‘Klebsiella spallanzanii’; Ko4, ‘Klebsiella pasteurii’; Ko6, K. grimontii; Ko8, K. 429 
huaxiensis (71–74)(75). K. michiganensis and K. oxytoca are distinguishable based on the blaOXY gene 430 
they carry (blaOXY-1 and blaOXY-2, respectively) (71). K. grimontii was recently described to 431 
accommodate Ko6 strains based on rpoB, gyrA and rrs gene sequences (73). All six members of the 432 
complex can be differentiated by MALDI-TOF (75), but reference databases currently in routine 433 
clinical use lack reference spectra of the different species to allow identification beyond K. oxytoca. 434 
Consequently, reports on complex members other than K. oxytoca have only recently begun to appear 435 
in the literature (73–77). The colonization of humans with K. oxytoca phylogroups has previously 436 
been associated with the genetic backgrounds of strains: Ko2 mainly inhabits the lower GI tract, with 437 
Ko1 and Ko6 generally associated with respiratory isolates and faecal isolates, respectively (72). 438 
On the basis of API 20E data and initial genome (MetaPhlAn2.6) analysis, five neonatal 439 
isolates were identified as K. oxytoca (#80, #83, #88, #99, #108). It has recently been shown that API 440 
20E and MALDI-TOF using current clinical reference databases are as effective as one another for 441 
characterization of complex members as K. oxytoca (78). MetaPhlAn2.6 cannot distinguish among 442 
species of the K. oxytoca complex. ANI of the genomes against reference genomes showed #88 and 443 
#108 to be K. michiganensis (both 98.78 and 98.94 % ANI, respectively with GCA_002925905) and 444 
#80, #83 and #99 to be K. grimontii (99.18, 99.23 and 99.17 % ANI, respectively, with 445 
GCA_900200035) (Supplementary Figure 5a), with ANI cut-off values well above the ~95 % 446 
proposed for species delineation (79–81) and used by Passet & Brisse (73) to separate K. grimontii 447 
from K. oxytoca and K. michiganensis. Phylogenetic analysis with a panel of authentic K. oxytoca, K. 448 
grimontii and K. michiganensis genomes confirmed the species affiliations of the infant isolates 449 
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(Supplementary Figure 5b). Similar to the K. pneumoniae isolates, no two infants harboured the 450 
same strain of K. michiganensis or K. grimontii (Figure 3a). 451 
It is notable that of the publicly available genomes deposited as K. oxytoca, 74 were found to 452 
represent K. michiganensis, 64 were K. oxytoca and 24 were K. grimontii. This suggests that K. 453 
michiganensis may be more clinically relevant than K. oxytoca sensu stricto. K. michiganensis was 454 
originally proposed to describe an isolate closely related to K. oxytoca recovered from a toothbrush 455 
holder (74). The bacterium is now recognised as an emerging pathogen, with this recognition due to 456 
improved genomic characterization of clinical isolates that would have previously been described as 457 
K. oxytoca based on simple phenotypic tests or MALDI-TOF (78,82–84). 458 
 459 
Predicted virulence and AMR determinant genes of infant-associated K. michiganensis and K. 460 
grimontii 461 
The K. michiganensis and K. grimontii strains were examined for the presence of virulence-462 
associated loci found in K. pneumoniae strains (53) (Figure 3b). Enterobactin was encoded by all 463 
strains. Yersiniabactin was predicted to be encoded by K. grimontii #99 and K. michiganensis #88 and 464 
#108. Other siderophore-associated gene clusters (aerobactin, colibactin and salmochelin) found in K. 465 
pneumoniae were absent. An allantoinase gene cluster (including allB/C/R/A/S and ybbW), which 466 
plays a role in K. pneumoniae liver infection (85), was identified in the three K. grimontii strains. 467 
Due to the clinical importance of AMR in Enterobacteriaceae, an in silico AMR gene profile 468 
was established for the K. michiganensis and K. grimontii strains. Homologues of 18 AMR 469 
determinant genes (acquired AMR genes – emrB, emrR; core AMR genes acrB, acrD, CRP, marA, 470 
mdtB, mdtC, baeR, FosA5, pmrF, oqxA, oqxB, msbA, KpnE, KpnF, KpnG, Escherichia ampH -471 
lactamase) were common to the five strains, similar to the K. pneumoniae isolates. Both K. 472 
michiganensis strains encoded homologues of OXY-1-2 (-lactamase specific to K. michiganensis 473 
(Ko1; (86)) and bacA, while #108 encoded a homologue of aph(3’)-la (aminoglycoside 474 
phosphotransferase). All K. grimontii strains encoded mdtN (potentially involved in resistance to 475 
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puromycin, acriflavine and tetraphenylarsonium chloride), while #83 and #99 encoded homologues of 476 
OXY-6-2 (-lactamase specific to K. grimontii (Ko6; (86)). 477 
 478 
Phenotypic characterization of K. pneumoniae, K. quasipneumoniae, K. michiganensis and K. 479 
grimontii neonatal isolates 480 
Five of the 13 Klebsiella strains we characterised were isolated from preterm infants who had 481 
been diagnosed with either NEC or sepsis. Thus, we sought to link our genotypic analyses with 482 
clinically important virulence traits including the ability to survive and replicate in host immune cells 483 
(i.e. macrophages) and the ability to produce iron-acquiring siderophores. We also determined the 484 
strains’ AMR profiles for a limited set of antimicrobials. 485 
Previous studies have indicated that respiratory infection-associated K. pneumoniae are able to 486 
survive within macrophages, a critical innate immune cell type required for optimal pathogen 487 
clearance (87). However, to date there is limited information relating to this ability in gut-associated 488 
strains, and there is no information on other Klebsiella species. Thus, all Klebsiella strains isolated in 489 
this study were tested in PMA-differentiated THP-1 macrophages using a gentamicin protection 490 
assay. All strains appeared to persist within macrophages, as bacterial load was either maintained over 491 
the time-course or increased or decreased between 1.5 h and 6 h, although these values were not 492 
statistically significant (Figure 4a). These data suggest that all Klebsiella strains tested can reside and 493 
persist in macrophages. This ability of all strains to survive, and in some cases potentially replicate, 494 
within macrophages indicates their immune evasion capabilities, which may link to increased risk and 495 
incidence of NEC and sepsis if these strains translocate from the ‘leaky’ preterm GI tract to systemic 496 
sites contributing to the inflammatory cascades characteristic of these conditions. 497 
Iron is a vital nutrient that performs multiple roles in cellular processes, ranging from DNA 498 
replication and cell growth to protection against oxidative stress. In the healthy host, the majority of 499 
iron is bound with intracellular proteins and the remaining free iron is extracellular and insoluble, 500 
hence difficult to access (88). For invading pathogens, siderophore systems are critical for iron 501 
competition and uptake to accomplish colonization and cause infections, this is particularly true in the 502 
preterm GI tract. Preterm infants in NICU are heavily supplemented with iron as they receive many 503 
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red-blood-cell transfusions (increasing hepatic iron stores), iron-supplemented parenteral nutrition, 504 
and supplementary oral iron within a few weeks of birth. During infection, Klebsiella secretes 505 
siderophores to sequester iron and to establish colonization in the host. Enterobactin is the most well-506 
known siderophore produced by K. pneumoniae and related species, and was found to be encoded by 507 
all our strains (Figure 2b, Figure 3b). The host innate immune protein lipocalin 2 binds to 508 
enterobactin and disrupts bacterial iron uptake (89). Klebsiella species have evolved to hoodwink this 509 
host response by producing several evasive siderophores (90,91). Siderophore production of 510 
Klebsiella isolates was monitored using CAS liquid assay. All isolates tested grown in M9 minimal 511 
medium were CAS-positive with the estimated siderophore concentration ranging between of 3.5 and 512 
6 nM (Figure 4b). There was no significant difference in siderophore production between ‘healthy’ 513 
and NEC- and sepsis-associated isolates. 514 
Klebsiella is of concern within an AMR context, particularly in at-risk neonates, due to the 515 
increasing emergence of multidrug-resistant isolates that cause severe infection (92). A UK study in 516 
which 24 % of all LOS cases were caused by Enterobacteriaceae (8.9 % of all caused by Klebsiella 517 
spp.) showed a high proportion (14 % and 34 %, respectively) of Enterobacteriaceae isolates 518 
recovered from sick infants were resistant to flucloxacillin/gentamicin and amoxicillin/cefotaxime, the 519 
two most commonly used empiric antibiotic combinations (51). Thus, to demonstrate antibiotic-520 
resistance phenotypes in Klebsiella spp. correlating to presence of AMR genotypes, we tested the 521 
susceptibility of the isolates with three antibiotics commonly prescribed in NICUs; gentamicin, 522 
meropenem and benzylpenicillin (Table 1). One strain of K. grimontii (#80) was potentially sensitive 523 
to benzylpenicillin, an aminopenicillin currently not recognized as being clinically useful against 524 
Enterobacteriaceae. 525 
Isolates #64, #83 and #108 (all encoding KpnG and KpnH; Figures 2a, 3b) were resistant to 526 
gentamicin, while #80, #88, #95 and #99 (all encoding KpnG and KpnH; Figures 2a, 3b) showed 527 
intermediate susceptibility to this aminoglycoside. 528 
Presence of a gene in a bacterium’s genome does not mean it is functionally active, nor does it 529 
give any indication as to how active the gene is if it is indeed functional: e.g. all nine K. pneumoniae 530 
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isolates encoded KpnG and KpnH (strict CARD matches; Figure 2a), but only two showed any 531 
resistance to gentamicin upon susceptibility testing. 532 
Isolates #64 (SHV-1), #74 (SHV-36), #85, #88, #91 (OKP-A-2), #92 (SHV-36), #95 (SHV-28), 533 
#102 (SHV-164), #115 (SHV-36) and #118 (SHV-36) – which all encoded extended-spectrum -534 
lactamases (SHV) or Escherichia ampH -lactamase (OKP-A-2) but lacked OmpK35 and OmpK36 – 535 
showed intermediate susceptibility to the carbapenem meropenem. Loss of the two porins OmpK35 536 
and OmpK36 is known to confer resistance to carbapenems in strains producing extended-spectrum β-537 
lactamases or plasmid-mediated AmpC-type β-lactamases (93). K. pneumoniae #64 was isolated from 538 
an infant with clinically diagnosed NEC with confirmed Klebsiella colonization. Importantly this 539 
preterm infant had previously been treated with benzylpenicillin, gentamicin and meropenem, which 540 
may link to the observed phenotypic resistance and corresponding AMR genes Escherichia ampH -541 
lactamase, blaSHV-1 and KpnG/KpnH and SHV-1, and lack of OmpK35 and OmpK36, and suggests 542 
further treatment with gentamicin and meropenem would have been ineffective in this infant. Indeed, 543 
the infant was treated with cefotaxime, metronidazole and vancomycin in a subsequent round of 544 
medication (Supplementary Table 2). K. pneumoniae #115 was isolated from a baby that had 545 
confirmed NEC: the strain was resistant to benzylpenicillin (encoded Escherichia ampH -lactamase 546 
and blaSHV-36) and showed intermediate resistance to meropenem (lacked OmpK35 and OmpK36). K. 547 
michiganensis #88, also isolated from a baby that had NEC, showed intermediate resistance to both 548 
benzylpenicillin (blaOXY-1-2, perfect CARD match; Figure 3b) and meropenem (lacked OmpK35 and 549 
OmpK36): both antibiotics had been administered to the baby at birth. K. grimontii #99, isolated from 550 
a baby with suspected sepsis, showed intermediate resistance to benzylpenicillin (encoded 551 
Escherichia ampH -lactamase and blaOXY-6-2). These data indicate that preterm-associated Klebsiella 552 
have a multi-drug-resistant phenotype that may prove problematic when treatment options are 553 
required for sepsis or NEC. Interestingly, other isolates (e.g. #95, recovered from an infant who had 554 
received benzylpenicillin and gentamicin; Supplementary Table 2) associated with ‘healthy’ preterm 555 
infants also harboured AMR genes (#95: Figure 2a) and phenotypic resistance profiles suggesting 556 
that administration of antibiotics to preterm infants with no signs of clinical infection contributes to 557 
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the reservoir of AMR genes – the ‘resistome’ (94) – which may increase horizontal gene transfer of 558 
AMR determinants to other opportunistic pathogens residing within the GI tract. 559 
 560 
Abundance of K. oxytoca and related species in metagenomic datasets 561 
We used a published metagenomics dataset (1) to determine the prevalence of K. oxytoca, K. 562 
michiganensis and K. grimontii in the preterm infant gut microbiome. These data had previously been 563 
used to look at the relationship between NEC and uropathogenic Esc. coli, and metadata were 564 
available for the samples. Ward et al. (1) collected a total of 327 samples at three stages of infant life: 565 
stage1, days 3–9; stage2, days 10–16; stage3, days 17–22. Within each life stage samples were 566 
collected on more than one day for some infants. In the current study, only samples processed under 567 
Protocol A of Ward et al. (1) and from the earliest collection day within each life stage were analysed. 568 
For those samples for which multiple sets of paired-end data were available, read data were 569 
concatenated and used in analyses (Supplementary Table 3). 570 
Stage1 comprised samples from 127 infants (105 preterm, 22 term), 16 of whom had been 571 
diagnosed with NEC and 10 infants had subsequently died. Stage2 comprised samples from 146 572 
infants (128 preterm and 18 term), 24 of whom later developed NEC with 18 deaths. Stage3 573 
comprised samples from 54 infants (48 preterm, 6 term), including eight NEC patients, six of whom 574 
died. Samples were collected from 165 distinct infants (143 preterm, 22 term) but only 41 of them 575 
were sequenced at all three life stages. Infants were born either vaginally (n = 70) or by caesarean 576 
section (n = 95). The gestational ages of preterm infants ranged from 23 to 29 weeks (mean 26.1 577 
weeks), while the term babies ranged from 38 to 41 weeks (mean 39.2 weeks). 578 
As we had found that the MetaPhlAn2.6 database contained non-K. oxytoca genomes within its 579 
K. oxytoca dataset (detecting K. oxytoca, K. michiganensis and R. ornithinolytica (refer to Methods)), 580 
we used Centrifuge to determine abundance of this species in metagenomes (Figure 5ab). Due to 581 
their genomic similarity, K. oxytoca and K. michiganensis could not be readily distinguished using 582 
Centrifuge (Figure 5a); no genomes assigned to K. grimontii were included in the Centrifuge 583 
database at the time this study was undertaken. Though it should be noted that, while Centrifuge (and 584 
Kraken2) relies on NCBI taxonomy for species identification, there are still many genomes within 585 
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GenBank/RefSeq that are assigned to the wrong species (e.g. assemblies GCA_001052235.1 and 586 
GCA_000427015.1 within our curated pangenome dataset have been confirmed by detailed analyses 587 
to be K. grimontii (Supplementary Figure 2 and (36)), but still assigned as K. oxytoca and K. 588 
michiganensis, respectively, within GenBank as of 28 July 2019; these are by no means the only 589 
examples from our current study). 590 
For those samples harbouring K. oxytoca, relative abundance of the bacterium increased from 591 
stage1 to stage2 and decreased at stage3 (Figure 5b). 592 
 593 
Metapangenome analysis of preterm infant metagenomic data to detect K. oxytoca, K. 594 
michiganensis and K. grimontii 595 
Using a set of 162 K. oxytoca-related genomes (Supplementary Table 4) and those of the five 596 
infant isolates, a pangenome was generated using Roary. The pangenome dataset consisted of 76 K. 597 
michiganensis (mean ANI among strains 98.55 (0.60) %, range 97.13–100 %), 64 K. oxytoca (mean 598 
ANI among strains 99.20 (0.30) %, range 98.53–100 %) and 27 K. grimontii (mean ANI among 599 
strains 98.45 (1.47) %, range 95.70–100 %) strains. A total of 40,605 genes were detected in the open 600 
pangenome: 2,769 of them constituted the core gene cluster, while the accessory cluster included 601 
5,108 genes and the remaining 32,728 genes formed the strain-specific cluster. A PCA plot based on 602 
the accessory genes clustered strains into the three different species (Figure 5c), in agreement with 603 
our phylogenetic analysis of the core genes (Supplementary Figure 5b) and consistent with the 604 
findings of (76), who were able to split the three species (phylogroups) based on a pangenome 605 
analysis of fewer genomes. 606 
The Roary-generated pangenome was used as a custom database for PanPhlAn, to detect the 607 
presence and absence of core genes and accessory genes in each infant sample. As expected, the 608 
proportion of reads that PanPhlAn mapped to the custom database correlated with the Centrifuge-609 
generated abundance data (Figure 5d). In stage1, 13 infants (12 preterm, 1 term; 10.2 % of all stage1 610 
samples) were predicted to carry K. oxytoca-related species (Figure 5e); in stage2, the number was 24 611 
(22 preterm, 2 term; 16.4 % of all stage2 samples) (Figure 5f); in stage3 infants, the rate of carriage 612 
was much lower, with only three infants (all preterm; 5.6 % of all stage3 samples) potentially 613 
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harbouring target species (Figure 5g). The change in prevalence of K. oxytoca-related species across 614 
the three stages based on the PanPhlAn analysis was consistent with the K. oxytoca abundance data 615 
generated with Centrifuge (Figure 5b). 616 
The pangenome accessory genes were used in PCA to define which species strains detected by 617 
PanPhlAn belonged to. In stage1, samples from six preterm infants (P10111, P10141, P10301, 618 
P10451, P11292, P12121) and one term infant (P30221) harboured K. michiganensis (Figure 5e). In 619 
stage2, samples from four preterm infants (P10471, P10472, P11311, P11701) harboured K. oxytoca, 620 
while those from 14 preterm infants (P10071, P10231, P10301, P10441, P10451, P10501, P10601, 621 
P11151, P11202, P11291, P11292, P12121, P12641, P12651) and one term infant (P30221) 622 
harboured K. michiganensis (Figure 5f). Four samples (P11351, P12621, P20241, P30141) could not 623 
be assigned a species, while the sample from P11981 located close to K. oxytoca (Figure 5f). 624 
Similarly, two of the stage3 samples from P12221 and P12651 carried K. michiganensis, while 625 
P11981 located near K. oxytoca (Figure 5g). 626 
 627 
Recovery of K. oxytoca and K. michiganensis MAGs from metagenomes 628 
Since the abundance of K. oxytoca-related species was considerable in some infant samples, we 629 
attempted to obtain high-quality MAGs directly from these metagenomes and to assign them to the 630 
species. The metagenomic samples were checked and their reads aligned against those of the 167-631 
genome database; reads that mapped were extracted and assembled as ‘original MAGs’. The genome 632 
sizes of the 167 genomes ranged from 5.72 Mb to 7.23 Mb (mean 6.35 Mb), thus a genome size of at 633 
least 5.5 Mb was used to define a likely complete MAG. After assembly of the reads that mapped to 634 
our database, MAGs were generated from the stage 1 (_s1), stage2 (_s2) and stage3 (_s3) samples. 635 
ANI and phylogenetic analyses showed these MAGs to be K. michiganensis (P10301_s1, P10451_s1, 636 
P11292_s1, P12121_s1, P30221_s1, P10071_s2, P10301_s2, P10441_s2, P10451_s2, P10501_s2, 637 
P10601_s2, P11151_s2, P11202_s2, P11291_s2, P11292_s2, P12121_s2, P12641_s2, P12651_s2, 638 
P30221_s2, P12221_s3 and P12651_s3; mean ANI with GCA_002925905 of 98.61  0.66 %) or K. 639 
oxytoca (P10472_s2, P11311_s2, P11701_s2, P11981_s2; mean ANI with GCA_900083895 of 99.30 640 
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 0.26 %) (36). No K. grimontii MAGs were recovered from any samples. 641 
Prior to checking the completeness and contamination of the K. michiganensis and K. oxytoca 642 
MAGs, contigs <500 nt in length were removed from the assemblies. A high-quality MAG requires a 643 
>90 % genome completeness with contamination <5 % (44). According to CheckM results, three 644 
stage1 MAGs (P10301_s1, P10451_s1, P30221_s1), seven stage2 MAGs (P10441_s2, P10451_s2, 645 
P10501_s2, P10601_s2, P11291_s2, P11292_s2, P30221_s2) and one stage3 MAG (P12221_s3) were 646 
of high quality. The rest of the MAGs were ≥90 % complete, but were contaminated (e.g. P12621_2 647 
contained 274.59 % contamination). Thus, we attempted to decontaminate the MAGs using a 648 
Diamond BLAST-based approach. 649 
Since we already knew the species each MAG belonged to from PCA and PanPhlAn analyses, 650 
scaffolds were mapped against the relevant species-specific genome database under different 651 
minimum BLAST identity to report alignments, which were used to generate ‘cleaner’ MAGs. 652 
Supplementary Figure 6 shows the change in genome completeness and the percentage 653 
contamination of stage2 MAGs when different blast identities were applied. The changes were 654 
negligible for those MAGs with high-quality-level completeness and lacking contaminants even when 655 
the cut-off was set at 99 %. For contaminated MAGs, the percentage contamination decreased 656 
markedly as the BLAST identity became stricter and reduced to the bottom when all scaffolds in that 657 
MAG could be aligned with 100 % identity. However, 100 % was not an appropriate threshold as the 658 
genome completeness was affected greatly at this point (Supplementary Figure 6). Instead, a cut-off 659 
of 99 % was used to decontaminate MAGs because 13 high-quality level MAGs and 5 medium-660 
quality level MAGs could be obtained when using this identity threshold. Stage2 MAGs that passed 661 
PanPhlAn, PCA and ANI analysis reached at least reach medium-quality level using a 99 % identity 662 
threshold. This cut-off was also suitable for stage1 MAGs, the quality of which was high. However, 663 
for stage3 MAGs, the percentage contamination from P11981_s3 decreased to medium-quality level 664 
only at 100 % identity, at which time the genome completeness fell down to 42.40 %. After 665 
evaluating their genome completeness and contamination levels, a total of 25 MAGs (Table 2) were 666 
assessed further. 667 
The presence of tRNAs for the standard 20 amino acids and rRNA was examined as a secondary 668 
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measure of genome quality. A high-quality MAG requires at least 18 of the 20 possible amino acids 669 
(44). P11981_s2 (16 aa) and P12651_s3 (17 aa) had to be classified as medium-quality MAGs even 670 
though their genome completeness and contamination reached high-quality levels. 16S rRNA genes 671 
were detected in all MAGs except P11151_s2, which was subsequently classified as medium quality. 672 
Taking mandatory genome information into consideration (44), a total of 19 high-quality and six 673 
medium-quality MAGs were recovered (Table 2); the sequences of these MAGs are available from 674 
figshare. All of the MAGs had ≥15 standard tRNAs. High-quality MAGs had tRNAs that encoded an 675 
average of 19.6 (0.7) of the 20 amino acids, some of them even had a tRNA that encodes an additional 676 
amino acid SeC, while medium-quality MAGs had 18 (1.4) basic amino acids encoded by tRNAs. 677 
High-quality MAGs consisted of ≤500 scaffolds in 52.6 % of cases (mean 600) and had an average 678 
N50 of 121 kb, while only one medium-quality MAG comprised ≤500 scaffolds (mean 1174) and the 679 
average N50 was less than half of that of high-quality MAGs (48.3 kb). 680 
 681 
Genotyping of MAGs 682 
Comparison of the sequences of the MAGs showed each infant harboured a different strain of K. 683 
oxytoca (Figure 6a) or K. michiganensis (Figure 6b). In infants where MAGs were recovered across 684 
different life stages, the MAGs were highly similar to one another (Figure 6b). Similar to what we 685 
had seen with our isolates, the MAGs encoded a range of -lactamase and virulence genes 686 
(Supplementary Figure 7). It was also notable that two of the MAGs (K. michiganensis 10071_s2, 687 
K. oxytoca 10472_s2) encoded mcr-9 (perfect match), a plasmid-mediated colistin resistance gene and 688 
phosphoethanolamine transferase. However, as noted above for our isolate work, presence of the 689 
aforementioned genes in MAGs does not mean they were functionally active in the infants’ GI tracts. 690 
All the K. michiganensis MAGs encoded the siderophore enterobacterin, along with all but one 691 
(11981_s2) of the K. oxytoca MAGs. The allantoinase gene cluster associated with liver infection was 692 
detected in the four K. oxytoca MAGs, but only a third of the K. michiganensis MAGs. We only 693 
detected this cluster in the K. grimontii isolates we recovered (Figure 3b). 694 
MLST analysis assigned 10 MAGs to eight known STs (Table 2). We believe insufficient 695 
sequence coverage meant we were unable to ST more MAGs: e.g. gapA of MAG P11981_s2 aligned 696 
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exactly with gapA allele 2 sequence but it was only partial, leaving an incomplete match. 697 
The STs of all genomes in the curated genome dataset were also identified (Supplementary 698 
Table 4). Due to our limited understanding of K. oxytoca-related species, many combinations of 699 
alleles have not been assigned corresponding STs yet, especially for the newly described species K. 700 
grimontii (73). MLST identification showed that 54/64 K. oxytoca sensu stricto strains had known 701 
STs, with some STs being more dominant than others. ST2, the most prevalent ST and represented by 702 
15 strains, belonged to CC2. ST18 and ST19 were also in CC2, with both represented by two strains. 703 
ST199 and ST176 were the second and third most common STs, respectively. Among K. 704 
michiganensis strains, 48/76 of them could be assigned a known ST and comprised 21 distinct STs, 705 
with nine represented by more than one isolate. ST11, ST27, ST50, ST85, ST143 and ST202 were the 706 
most frequent STs, all of which were represented by at least four strains. K. michiganensis #108 was 707 
ST157. Only 5/27 K. grimontii strains could be assigned an ST (#83 – ST72; #99 – ST76; 10-5250 – 708 
ST47, GCA_000247915.1; 1148_KOXY – ST186, GCA_001052235.1; M5al – ST104, 709 
GCA_001633115.1). 710 
 711 
SUMMARY 712 
Klebsiella spp. encode numerous virulence and antibiotic resistance genes that may contribute to 713 
the pathogenesis of NEC and LOS. In this study, we characterized nine K. pneumoniae, three K. 714 
grimontii and two K. michiganensis strains isolated prospectively from the faeces of a UK cohort of 715 
preterm infants, and have shown these gut isolates are able to reside and persist in macrophages, 716 
suggesting they can evade the immune system. These isolates will be used in future studies aiming to 717 
replicate aspects of NEC and sepsis in model systems to confirm the role of Klebsiella spp. in these 718 
diseases. 719 
We have shown that mis-annotated genomes are being used in bioinformatics tools routinely 720 
used to characterize the human gut microbiome. By using a carefully curated dataset to undertake 721 
metapangenome analyses of the closely related species K. oxytoca, K. michiganensis and K. grimontii, 722 
we have demonstrated that K. michiganensis is likely to be more clinically relevant to a subset of 723 
preterm infants than K. oxytoca. Identity of publicly available genomes should be confirmed upon 724 
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download and linked to accurate taxonomic frameworks prior to analyses of data, especially when 725 
attempting to identify and type closely related species in metagenomic data.  726 
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FIGURE LEGENDS 1048 
Figure 1. Summary information for UK cohort included in this study. (a) Breakdown of birth mode 1049 
and sex of preterm neonates. (b) 16S rRNA gene sequence results for Enterobacteriaceae-positive 1050 
samples: upper panel, samples from which lactose-positive isolates were recovered; lower panel, 1051 
samples from which lactose-negative isolates were recovered. (c) Representation of lactose-negative 1052 
and lactose-positive Enterobacteriaceae isolated from faecal samples. (d) Tentative identities of 1053 
lactose-positive Enterobacteriaceae as determined by using API 20E. 1054 
 1055 
Figure 2. Summary of (a) antibiotic resistance and (b) virulence factor genes found in the K. 1056 
pneumoniae isolates by comparison of protein sequences with those of the CARD and VFDB, 1057 
respectively. (a) Strict CARD match, not identical but the bit-score of the matched sequence is greater 1058 
than the curated BLASTP bit-score cut-off; perfect CARD match, 100 % identical to the reference 1059 
sequence along its entire length. Loose matches are not shown to avoid presenting false positives 1060 
based on sequences with low homology and bit-scores below CARD BLASTP cut-off 1061 
recommendations. (b) Identity (%), BLASTP reported only for those proteins sharing >70 % identity 1062 
and 90 % query coverage with VFDB protein sequences. 1063 
 1064 
Figure 3. Genomic characterization of the K. michiganensis and K. grimontii isolates recovered from 1065 
neonates. (a) Anvi’o representation of the genomes of K. michiganensis and K. grimontii isolates 1066 
recovered from different infants. It is clear the isolates are different from one another at the genomic 1067 
level. (b) Virulence factor (left side) and antibiotic resistance (right side) genes encoded by the 1068 
isolates. Criteria for identity and strict/perfect match with respect to VFDB and CARD, respectively, 1069 
are the same as those given for Figure 2. 1070 
 1071 
Figure 4. Phenotypic assays for the Klebsiella isolates recovered from infants. (a) Strains were tested 1072 
for persistence in PMA-differentiated THP-1 macrophages using a gentamicin protection assay. 1073 
Intracellular bacteria were enumerated 1.5 h and 6 h after infection to determine persistence (n=4). 1074 
Results are shown as mean (SD). (b) Klebseilla strains were grown in minimal medium and at 20 h 1075 
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bacterial growth (OD600) siderophore production was measured using the CAS assay (n = 3). Results 1076 
are shown as mean (SD). 1077 
 1078 
Figure 5. Identification of K. oxytoca-related species in infant faecal metagenomes. (a) Comparison 1079 
of K. oxytoca and K. michiganensis abundance (as determined using Centrifuge) in stage2 samples of 1080 
Ward et al. (1). (b) Abundance of K. oxytoca (determined using Centrifuge) across stage1, stage2 and 1081 
stage3 samples of Ward et al. (1). (c) Separation of the strains of K. grimontii (n=27), K. 1082 
michiganensis (n=76) and K. oxytoca (n=64) based on accessory genes (n = 5,108) detected in the 1083 
Roary-generated open pangenome. (d) Relationship between PanPhlAn (overall alignment rate) and 1084 
Centrifuge (abundance K. oxytoca (%)) data. (e, f, g) PCA plots show separation of strains in the 1085 
pangenome plus PanPhlAn-detected strains based on presence of 500 randomly sampled accessory 1086 
genes at (e) stage1, (f) stage2 and (g) stage3 of Ward et al. (1). 1087 
 1088 
Figure 6. Anvi’o representation of the MAGs recovered from the metagenomes of infants included in 1089 
the study of Ward et al. (1). (a) K. oxytoca. (b) K. michiganensis. It is notable that MAGs recovered 1090 
from different life stages from the same infant (e.g. 10301_s1, 10301_s2) are highly similar to one 1091 
another. 1092 
  1093 
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Table 1. Determination of MICs for Klebsiella spp. isolates 1094 
Isolate ID Species Gentamicin (mg/L)* Meropenem (mg/L)† Benzylpenicillin (mg/L)‡ 
#64 K. pneumoniae 6.25# 3.13 1560 
#74 K. pneumoniae 1.5625 6.25 3130 
#85 K. pneumoniae 1.5625 3.13 3130 
#91 K. quasipneumoniae 1.5625 6.25 3130 
#92 K. pneumoniae 1.5625 3.13 3130 
#95 K. pneumoniae 3.125 3.13 3130 
#102 K. pneumoniae 1.5625 6.25 3130 
#115 K. pneumoniae 1.5625 3.13 3130 
#118 K. pneumoniae 1.5625 6.25 3130 
#80 K. grimontii 3.125 1.56 6.25 
#83 K. grimontii 12.5 1.56 780 
#99 K. grimontii 3.125 0.78 780 
#88 K. michiganensis 3.125 3.13 3130 
#108 K. michiganensis 6.25 1.56 3130 
*Enterobacteriaceae EUCAST breakpoint for gentamicin resistance is >4 mg/L, and for sensitivity is 1095 
≤2 mg/L. 1096 
†Enterobacteriaceae EUCAST breakpoint for meropenem is resistance >8 mg/L, and for sensitivity is 1097 
≤2 mg/L. 1098 
‡No Enterobacteriaceae EUCAST data are available for benzylpenicillin. 1099 
#Bold type, resistant; underlined, intermediate. 1100 
 43 
Table 2. Summary statistics for MAGs recovered from preterm infant metagenomes 1101 
MAG* Genome 
length 
(bp) 
Max. 
contig 
length 
Coverage† N50 No. of 
scaffolds 
GC 
content 
(%) 
Completeness (%)‡ Contamination (%)‡ CDS No. of 
tRNAs 
No. of 
rRNAs 
Species Quality gapA infB mdh pgi phoE rpoB tonB ST 
10071_s2 6,577,866 334,901 ~131x 70,229 349 52.95 97.59 3.64 6204 54 3 K. michiganensis High 3 9 8 9 20 * 8 * 
10301_s1 6,304,211 308,355 ~158x 143,120 176 53.15 99.70 0.48 5920 54 4 K. michiganensis High 3 5 21 13 74 6 12 202 
10301_s2 6,504,340 160,223 ~21x 30,917 609 54.93 98.69 4.21 6191 50 2 K. michiganensis Medium 3 5 21 13 74 6 12 202 
10441_s2 6,128,395 396,555 ~85x 122,210 176 53.35 100.00 0.71 5691 58 4 K. michiganensis High 3 5 21 13 24 6 * * 
10451_s1 6,135,593 499,885 ~79x 130,343 154 53.44 100.00 0.71 5708 53 7 K. michiganensis High 3 5 21 13 24 6 * * 
10451_s2 6,140,759 377,549 ~65x 130,433 166 53.53 100.00 0.71 5707 54 4 K. michiganensis High 3 5 21 13 24 6 * * 
10472_s2 6,352,656 271,779 ~46x 80,647 252 53.26 99.90 2.59 5889 50 3 K. oxytoca High 1 7 2 1 65 1 2 176 
10501_s2 6,179,579 451,918 ~39x 133,209 217 54.01 100.00 1.34 5730 55 9 K. michiganensis High 3 5 21 3 24 6 * * 
10601_s2 6,014,627 328,826 ~59x 181,417 121 52.63 99.96 0.34 5540 56 4 K. michiganensis High 3 5 21 3 24 6 * * 
11151_s2 6,595,368 114,676 ~40x 17,470 949 54.71 97.17 5.81 6252 59 0 K. michiganensis Medium 3 5 21 13 20 * 12 * 
11202_s2 6,328,179 267,673 ~144x 111,043 224 53.38 98.81 3.22 5864 54 3 K. michiganensis High * 8 24 33 20 6 23 * 
11291_s2 6,301,261 429,108 ~45x 146,444 193 53.10 99.70 0.79 5911 68 8 K. michiganensis High 3 8 17 21 40 17 29 84 
11292_s1 6,533,348 267,672 ~43x 118,981 400 53.17 98.81 2.77 6064 48 3 K. michiganensis High * 8 24 33 20 6 23 * 
11292_s2 6,383,200 267,500 ~70x 119,207 202 50.77 99.70 2.49 5891 63 8 K. michiganensis High * 8 24 33 20 6 23 * 
11311_s2 6,427,314 266,393 ~137x 66,881 516 52.89 99.97 2.96 5986 46 1 K. oxytoca Medium 2 2 2 3 19 2 2 199 
11701_s2 6,230,855 162,114 ~60x 50,736 555 54.40 99.85 3.20 5807 50 2 K. oxytoca Medium 1 7 2 1 65 1 2 176 
11981_s2 5,658,923 237,765 ~10x 60,298 326 53.62 89.43 2.20 5280 30 2 K. oxytoca Medium * 2 2 3 19 * 2 * 
12121_s1 5,843,313 426,086 ~121x 101,108 251 54.02 96.40 2.49 5358 53 4 K. michiganensis High 3 33 17 45 20 6 48 149 
12121_s2 5,690,611 180,068 ~82x 56,100 371 54.36 94.21 2.85 5226 35 3 K. michiganensis High 3 33 17 45 20 * 48 * 
12221_s3 6,115,156 469,104 ~17x 174,402 147 54.67 99.70 1.60 5667 63 8 K. michiganensis High 3 5 21 20 24 6 30 108 
12641_s2 6,383,005 237,677 ~55x 80,508 279 53.91 99.44 3.15 6027 56 2 K. michiganensis High 3 5 21 13 74 * 12 * 
12651_s2 5,124,388 199,319 ~28x 81,423 207 53.59 94.05 3.21 4801 42 3 K. michiganensis High 14 24 15 8 18 * 4 * 
12651_s3 5,422,817 363,696 ~10x 73,253 207 53.78 95.49 2.40 5047 41 2 K. michiganensis Medium 14 2 15 8 18 * 4 * 
30221_s1 6,220,970 480,926 ~51x 173,840 132 52.47 99.70 1.42 5770 61 9 K. michiganensis High 3 5 21 20 11 6 20 43 
30221_s2 6,224,584 349,605 ~55x 170,314 142 52.27 99.70 1.39 5765 58 7 K. michiganensis High 3 5 21 20 11 6 20 43 
*E.g. 10301_s1 represents a MAG recovered from infant 10301 at stage1. 1102 
†Coverage, based on coverage of longest contig (determined from spades data). 1103 
‡Completeness and contamination determined using CheckM (v1.0.18). 1104 
